Peptomyc

Barcelona, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

Mar 2026

Venture - Series Unknown

Biotechnology Health Care Oncology Wellness

Top Investors

European Innovation CouncilEuropean CommissionCentre for the Development of Industrial Technology (CDTI)EISMEAHorizon 2020

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Peptomyc

Who are Peptomyc's investors?

Peptomyc's investors include European Innovation Council, European Commission, Centre for the Development of Industrial Technology (CDTI), EISMEA, Horizon 2020.

Where is Peptomyc headquartered?

Peptomyc is headquartered in Barcelona, Spain.

What does Peptomyc do?

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

What stage is Peptomyc at?

Peptomyc is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2026.

MLA

"Peptomyc — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/peptomyc. Accessed July 1, 2026.

APA

VCBacked. (2026). Peptomyc — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/peptomyc

Wikipedia (cite web)

{{cite web |title=Peptomyc — Funding & Investors |url=https://www.vcbacked.co/company/peptomyc |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.